Christopher K. Prier

Statistics

Publications

Citations

2.4K

H-Index

Active since

2011

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

California Institute of Technology

Princeton University

KTH Royal Institute of Technology

Science for Life Laboratory

Christopher K. Prier is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in biocatalysis, catalytic mechanisms, and biochemistry.

ORCID

Publications per year

2011–2025

Publications

Discovery of an α-Amino C–H Arylation Reaction Using the Strategy of Accelerated Serendipity

Andrew McNally, Christopher K. Prier, David W. C. MacMillan · Science · 2011 · 1K citations

Natural Sciences, Chemistry, Medicinal Chemistry +8

Enantioselective, intermolecular benzylic C–H amination catalysed by an engineered iron-haem enzyme

Christopher K. Prier, Ruijie K. Zhang, Andrew R. Buller et al. · Nature Chemistry · 2017 · 385 citations · Full text

Natural Sciences, Biochemistry, Chemistry +12

Amine α-heteroarylation via photoredox catalysis: a homolytic aromatic substitution pathway

Christopher K. Prier, David W. C. MacMillan · Chemical Science · 2014 · 177 citations

Natural Sciences, Chemistry, Medicinal Chemistry +13

Chemomimetic Biocatalysis: Exploiting the Synthetic Potential of Cofactor-Dependent Enzymes To Create New Catalysts

Christopher K. Prier, Frances H. Arnold · Journal of the American Chemical Society · 2015 · 159 citations · Full text

Life Sciences, Biochemistry, Biocatalysis +12

Enantioselective Aminohydroxylation of Styrenyl Olefins Catalyzed by an Engineered Hemoprotein

Inha Cho, Christopher K. Prier, Zhi‐Jun Jia et al. · Angewandte Chemie International Edition · 2019 · 135 citations

Life Sciences, Biochemistry, Biotechnology +17

1–5 of 17